AR was suspected in promoting invasiveness of both androgen-dependent and independent prostate cancer; its expression affects EGFR-mediated signaling, and targeting EGFR in androgen-independent prostate cancer could inhibit tumor proliferation and invasion. Here, EGFR is linked to prostate carcinoma.